Figure 1.
Change in haematocrit over time by anaemia status. Compared to placebo, empagliflozin increased haematocrit and haemoglobin at all time‐points in patients with and without anaemia at baseline. SE, standard error.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.